2023-11-13T12:21:52-06:00 2021-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVE STE 500 BETHESDA MD 20814 990 2021-01-01 522252820 ASSOCIATION FOR ACCESSIBLE MEDICINES ASSO 2022497100 601 NEW JERSEY AVENUE NW 850 WASHINGTON DC 20001 DAVID GAUGH INTERIM CHIEF EXECUTIVE OFFICER 2022497100 2023-11-10 1 DAVID GAUGH 999009999 MARK THOMAS P00362982 3019860600 2023-11-10 3 AAL1 IAL1 2021 2023-04-26 12:10:37Z X DAVID GAUGH 601 NEW JERSEY AVENUE NW 850 WASHINGTON DC 20001 26057022 0 X WWW.ACCESSIBLEMEDS.ORG X 2000 DC PROMOTE THE INTEREST OF THE GENERIC PHARMACEUTICAL AND BIOSIMILAR INDUSTRY. 21 21 38 316 0 0 0 0 25452651 25453104 87298 58057 500 11823 25540449 25522984 290152 271108 0 0 10300541 10974580 0 0 0 14038448 12327857 24629141 23573545 911308 1949439 11604954 18090132 4151968 8691351 7452986 9398781 THE ORGANIZATION FOSTERS AND PROMOTES THE INTERESTS OF THE GENERIC PHARMACEUTICAL AND BIOSIMILAR INDUSTRY. 0 0 GOVERNMENT AFFAIRS - ADVOCATE ON BEHALF OF THE GENERIC PHARMACEUTICAL AND BIOSIMILAR INDUSTRY WITH RESPECT TO FEDERAL, STATE, AND MUNICIPAL RULES, LAWS, AND ORDERS AFFECTING THE INDUSTRY. POLICY & STRATEGIC ALLIANCES - IDENTIFY POLICY ISSUES AFFECTING THE GENERIC DRUG AND BIOSIMILARS INDUSTRIES AND FACILITATE DEVELOPMENT OF POLICY POSITIONS AMONG OUR MEMBER COMPANIES; WORK WITH THE AGENCIES OF THE U.S. GOVERNMENT, AND STATE AND INTERNATIONAL BODIES TO EDUCATE AND COMMUNICATE POLICY POSITIONS ON STRATEGIC PRIORITIES; DEVELOP DATA TO SUPPORT ADVOCACY INITIATIVES AND PUBLISH WHITE PAPERS, REPORTS AND OTHER POLICY RESOURCES; BUILD RELATIONSHIPS WITH THIRD-PARTY STAKEHOLDERS ACROSS SUPPLY CHAIN, PATIENT, PROVIDER, CONSUMER, AND OTHER SECTORS TO SUPPORT ADVOCACY INITIATIVES. COMMUNICATIONS & MARKETING - EDUCATING POLICYMAKERS, MEDIA, PATIENTS AND OTHER STAKEHOLDERS ABOUT THE ECONOMIC AND THERAPEUTIC CONTRIBUTIONS OF GENERIC AND BIOSIMILAR MEDICINES AS WELL AS THEIR SAFETY AND EFFICACY; PRODUCING AND SHARING PATIENT AND TAXPAYER SAVINGS DATA AND STORIES OF PATIENTS WHOSE HEALTH IS SAVED, IMPROVED AND MAINTAINED BY GENERIC AND BIOSIMILAR MEDICINES; DISSEMINATING INSTRUCTIONAL MATERIALS AND CURRICULUM TO PROMOTE THE SAFE USE, STORAGE AND DISPOSAL OF PRESCRIPTION MEDICINES. 0 0 0 1 0 0 0 0 0 1 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 72 0 1 38 1 0 0 0 0 0 0 0 0 0 0 X 21 21 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X THE ASSOCIATION 2022497100 601 NEW JERSEY AVE NW SUITE 850 WASHINGTON DC 20001 SONIG ALOK CHAIR 2.00 X X 0 0 0 HARDWICK PETER VICE CHAIR 2.00 X X 0 0 0 HOFFMANN BRIAN TREASURER 2.00 X X 0 0 0 HAMPTON JEFF DIRECTOR 2.00 X 0 0 0 DIOLOSA PAUL DIRECTOR 2.00 X 0 0 0 MANZANO STEPHEN DIRECTOR 2.00 X 0 0 0 DISCHNER DAN DIRECTOR 2.00 X 0 0 0 MURDOCK HUNTER DIRECTOR 2.00 X 0 0 0 MCMAHON PAUL DIRECTOR 2.00 X 0 0 0 VERMA ARUNESH DIRECTOR 2.00 X 0 0 0 BRILL VANESSA DIRECTOR 2.00 X 0 0 0 DUCKER JOHN DIRECTOR 2.00 X 0 0 0 KRISHNAN SANJEEV DIRECTOR 2.00 X 0 0 0 FULLEM TERRY DIRECTOR 2.00 X 0 0 0 MANN AARON DIRECTOR 2.00 X 0 0 0 GAVARIS SPIRO DIRECTOR 2.00 X 0 0 0 MOORE DANIEL DIRECTOR 2.00 X 0 0 0 PANDYA HEM DIRECTOR 2.00 X 0 0 0 MANCINELLI II VINCENT DIRECTOR 2.00 X 0 0 0 KAMMERER PETER DIRECTOR 2.00 X 0 0 0 LYNCH CAROL DIRECTOR 2.00 X 0 0 0 HARUVI KEREN DIRECTOR 2.00 X 0 0 0 BALDOTA UDAY DIRECTOR 2.00 X 0 0 0 BAEDER CHRISTINE DIRECTOR 2.00 X 0 0 0 KEEFE GEORGE DIRECTOR 2.00 X 0 0 0 RENNER JOESEPH DIRECTOR 2.00 X 0 0 0 DUNCAN JOANNE CHIEF OPERATING OFFICER 40.00 X X 271325 0 8692 FRANCER JEFFREY SVP & GENERAL COUNSEL 40.00 X 675214 0 50620 MCDERMOTT-VITAK ANNA SR. VP, DEVELOPMENT & ADMIN 40.00 X 531828 0 51125 LEONARD DANIEL PRESIDENT & CEO 40.00 X 1301422 0 103678 GAUGH DAVID SR. VP, SCIENCES & REG AFF 40.00 X 604004 0 44465 SIMMON CHRISTINE EVP, POLICY & STRAT ALLIANCE 40.00 X 580330 0 36949 GOLDBERG ALLEN SVP, COMMUNICATIONS 40.00 X 500974 0 48809 KOMENDANT ERIK SR. VP, GOVERNMENT AFFAIRS 40.00 X 446065 0 36660 KIMBALL JONATHAN VP, INTL AFFAIRS & STRAT INITIATIVES 40.00 X 366736 0 46326 5277898 0 427324 26 0 1 0 FIREHOUSE STRATEGIES 1501 M STREET NW SUITE 1100 WASHINGTON DC 20005 CONSULTING SERVICES 667500 IQVIA INC 100 IMS DRIVE PARSIPPANY NJ 07054 RESEARCH STUDIES 530685 KIRKLAND & ELLIS 601 LEXINGTON AVENUE NEW YORK NY 10022 LEGAL SERVICES 450000 MODEL B 900 7TH ST 970 WASHINGTON DC 20001 DIGITAL STRATEGIES 446620 AVALERE HEALTH 1201 NEW YORK AVENUE NW SUITE 1000 WASHINGTON DC 20005 ANALYTIC SERVICES 387000 30 MEMBERSHIP DUES 999009 24116287 24116287 BIOSIMILAR DIVISIONAL DUES 999009 670000 670000 MEETING REVENUE 999009 666817 666817 25453104 26914 26914 565181 534038 31143 31143 31143 MISCELLANEOUS 999009 11823 11823 11823 25522984 25464927 0 58057 X 271108 2921514 6870044 297775 416228 469019 1605676 113226 2639157 3524060 1048175 205141 343872 965971 52290 282735 282528 75052 DUES & SUBSCRIPTIONS 706822 RESEARCH PROJECT 457115 MISCELLANEOUS 26037 23573545 1147059 4915002 5023526 7522764 35216 121396 204764 286782 2771026 1367538 1673546 1403488 275000 592059 3238723 3241521 7120 7120 11604954 18090132 1244265 1345624 66800 4738049 2840903 2607678 4151968 8691351 X 7452986 9398781 7452986 9398781 11604954 18090132 1949439 -3644 0 X X 0 1 X 1 0 0 0 0 24786287 5515257 -8802175 -3286918 8912063 -12198981 1752500 687540 1064960 905250 567556 337694 113276 112442 834 1403488 CERTIFICATE OF DEPOSITS 3241521 C 3241521 DEFERRED RENT AND LEASE INCENTIVE 2131405 SUBLEASE LIABILITY 401513 DEFERRED COMPENSATION PAYABLE 74760 2607678 X PART X, LINE 2: THE ASSOCIATION REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THE ASSOCIATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. 0 AFPE 6076 FRANCONIA ROAD SUITE C ALEXANDRIA VA 22310 530214882 501C3 10000 0 GENERAL CONTRIBUTION ALLIANCE FOR RETIRED AMERICANS 815 16TH STREET NW 4TH FLOOR NORTH WASHINGTON DC 20006 522277805 501C3 15000 0 GENERAL CONTRIBUTION AMERICAN CONSUMER INSTITUTE CCR 1701 PENNSYLVANIA AVENUE NW SUITE 200 WASHINGTON DC 20006 208601897 501C3 25000 0 GENERAL CONTRIBUTION BLACK WOMEN'S HEALTH IMPERATIVE 700 PENNSYLVANIA AVENUE SE SUITE 2059 WASHINGTON DC 20003 581557556 501C3 10000 0 GENERAL CONTRIBUTION CITIZENS AGAINST GOVERNMENT WASTE 1100 CONNECTICUT AVENUE NW SUITE 650 WASHINGTON DC 20036 521363952 501C3 15000 0 GENERAL CONTRIBUTION CONSUMER ACTION 57 POST STREET SUITE 611 SAN FRANCISCO CA 94104 237172908 501C3 12500 0 GENERAL CONTRIBUTION NATIONAL MULTIPLE SCLEROSIS SOCIETY 900 SOUTH BROADWAY 2ND FLOOR DENVER CO 80209 135661935 501C3 10000 0 GENERAL CONTRIBUTION NATIONAL TAXPAYERS UNION 122 C STREET NW SUITE 650 WASHINGTON DC 20001 521009116 501C4 45000 0 GENERAL CONTRIBUTION PREVENT CANCER FOUNDATION 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501C3 15000 0 GENERAL CONTRIBUTION R STREET INSTITUTE 1212 NEW YORK AVENUE NW SUITE 900 WASHINGTON DC 20005 263477125 501C3 45000 0 GENERAL CONTRIBUTION TAXPAYERS PROTECTION ALLIANCE 1401 K STREET NW SUITE 502 WASHINGTON DC 20005 450702828 501C4 10000 0 GENERAL CONTRIBUTION WASHINGTON LEGAL FOUNDATION 2009 MASSACHUSETTS AVENUE NW WASHINGTON DC 20036 521071570 501C3 15000 0 GENERAL CONTRIBUTION REPUBLICAN STATE LEADERSHIP COMMITTEE 1201 F STREET NW SUITE 675 WASHINGTON DC 20004 050532524 527 10000 0 GENERAL CONTRIBUTION 10 3 X X X 1 1 X X X X X X 1 1 0 LEONARD DANIEL PRESIDENT & CEO 761132 0 467900 0 72390 0 74761 0 28917 0 1405100 0 0 0 FRANCER JEFFREY SVP & GENERAL COUNSEL 406431 0 268783 0 0 0 23200 0 27420 0 725834 0 0 0 GAUGH DAVID SR. VP, SCIENCES & REG AFF 448400 0 155604 0 0 0 23200 0 21265 0 648469 0 0 0 SIMMON CHRISTINE EVP, POLICY & STRAT ALLIANCE 414406 0 165924 0 0 0 23200 0 13749 0 617279 0 0 0 MCDERMOTT-VITAK ANNA SR. VP, DEVELOPMENT & ADMIN 288273 0 105252 0 138303 0 20833 0 30292 0 582953 0 0 0 GOLDBERG ALLEN SVP, COMMUNICATIONS 344476 0 156498 0 0 0 20917 0 27892 0 549783 0 0 0 KOMENDANT ERIK SR. VP, GOVERNMENT AFFAIRS 307393 0 138672 0 0 0 19500 0 17160 0 482725 0 0 0 KIMBALL JONATHAN VP, INTL AFFAIRS & STRAT INITIATIVES 276772 0 89964 0 0 0 21676 0 24650 0 413062 0 0 0 DUNCAN JOANNE CHIEF OPERATING OFFICER 187210 0 84115 0 0 0 0 0 8692 0 280017 0 0 0 PART I, LINES 4A-B DURING THE YEAR ENDED DECEMBER 31, 2021, THE ASSOCIATION MADE CONTRIBUTIONS OF $289,560 TO A 457(F) SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN FOR DANIEL LEONARD, PRESIDENT & CEO. PER THE 457(F) PLAN DOCUMENT, THE CONTRIBUTIONS VEST OVER A THREE-YEAR PERIOD BEGINNING IN 2021 BASED ON CONTINUED EMPLOYMENT. DURING THE YEAR ENDED DECEMBER 31, 2021, ANNA MCDERMOTT-VITAK RECEIVED A SEVERANCE PAYMENT OF $138,303. FORM 990, PART VI, SECTION A, LINE 6 AAM HAS ONE CLASS OF REGULAR VOTING MEMBERS THAT MUST MEET THE FOLLOWING CRITERIA. A REGULAR MEMBER SHALL BE A CORPORATION, PARTNERSHIP OR OTHER LEGAL ENTITY THAT DERIVES MORE THAN TWENTY-FIVE PERCENT (25%) OF ITS NET REVENUES IN THE UNITED STATES FROM THE DEVELOPMENT, COMMERCIALIZATION, MANUFACTURE, SALE AND/OR MARKETINGS OF FINISHED DOSE PRODUCTS THAT ARE (1) PRODUCTS DESCRIBED IN ABBREVIATED NEW DRUG APPLICATIONS FILED WITH THE U.S. FOOD & DRUG ADMINISTRATION; (2) PRODUCTS SOLD AS AUTHORIZED GENERIC DRUGS IN THE U.S., (3) BIOSIMILAR PRODUCTS, AS DESCRIBED IN SECTION 351(K) OF THE PUBLIC HEALTH SERVICE ACT, AS AMENDED; AND/OR (4) DRUG EFFICACY STUDY IMPLEMENTATION (DESI) PRODUCTS. REGULAR MEMBERS HAVE FULL VOTING RIGHTS ON A "ONE COMPANY, ONE VOTE" BASIS. EACH REGULAR MEMBER SHALL DESIGNATE IN WRITING ONE PERSON TO EXERCISE THE RIGHTS OF THE REGULAR MEMBER IN THIS ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 7A AAM'S VOTING MEMBERS ELECT THE DIRECTORS OF AAM'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B PURSUANT TO AAM'S BYLAWS, AAM'S BOARD OF DIRECTORS HAVE THE AUTHORITY TO AMEND THE BYLAWS. FURTHER, PURSUANT TO THE D.C. NOT-FOR-PROFIT CORPORATION ACT, EXTRAORDINARY ACTIONS MUST BE APPROVED BY THE VOTING MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B AAM STAFF AND LEGAL COUNSEL PROVIDE INITIAL REVIEW OF THE FORM 990. THE FORM 990 IS THEN REVIEWED BY THE AUDIT & FINANCE COMMITTEE. FINALLY IT IS FORWARDED TO ALL THE DIRECTORS OF THE BOARD BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C AAM REGULARLY AND CONSISTENTLY MONITORS COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY BY REMINDING DIRECTORS AND OTHERS SUBJECT TO THE POLICY PERIODICALLY OF THE APPLICABILITY OF THE POLICY AND THE APPROPRIATE MANNER OF COMPLYING WITH THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF THE PRESIDENT IS DETERMINED BASED ON THE PERFORMANCE OF THE PRESIDENT AND COMPARABLE SALARIES OF EXECUTIVES OF SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. FINAL APPROVAL OF THE PRESIDENT'S COMPENSATION IS MADE BY THE EXECUTIVE COMMITTEE OF THE BOARD, ALL OF WHOM ARE INDEPENDENT DIRECTORS. COMPENSATION OF OTHER OFFICERS AND KEY EMPLOYEES IS DETERMINED BY THE PRESIDENT BASED ON COMPENSATION DATA OF SIMILARLY SITUATED EMPLOYEES AT SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS 3,261,222. PAYROLL PROCESSING FEES 12,643. EXECUTIVE SEARCH EXPENSE 250,195. FORM 990, PART XII, LINE 2C: THE FINANCE AND AUDIT COMMITTEE OF THE BOARD OVERSEES THE AUDIT AND RECOMMENDS SELECTION OF AN INDEPENDENT AUDITOR BY THE BOARD. THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. AMENDED 990: PART VII SECTION A LINE 1A: DANIEL LEONARD'S COLUMN (D) REPORTABLE COMPENSATION WAS INCREASED $72,390 FROM $1,229,032 TO $1,301,422 FOR 457(F) INCLUDED AS TAXABLE INCOME. SCHEDULE J PART II: DANIEL LEONARD'S COLUMNS (B)(III), OTHER REPORTABLE COMPENSATION WAS INCREASED FROM $0 TO $72,390 FOR 457(F) INCLUDED AS TAXABLE INCOME. AS A RESULT COLUMN (E) WAS CHANGED FROM 1,332,710 TO 1,405,100. ASSOCIATION FOR ACCESSIBLE MEDICINES EDUCATION FOUNDATION 601 NEW JERSEY AVE NW SUITE 850 WASHINGTON DC 20001 453526383 SEE PART VII - SUPPLEMENTAL INFORMATION DC 501(C)(3) LINE 7 ASSOCIATION FOR ACCESSIBLE MEDICINES 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0